Pharming Group N.V.
PHAR
$11.72
-$0.63-5.10%
NASDAQ
Corporate Info
Website
Phone Number
31 71 524 7400
Address
Darwinweg 24
Leiden, 2333 CR
Leiden, 2333 CR
Country
Netherlands
Year Founded
1988
Details
Sector
--
Industry
--
Employees
407
Business Description
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company’s lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K? inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.